1. Home
  2. WULF vs BIO Comparison

WULF vs BIO Comparison

Compare WULF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

HOLD

Current Price

$13.86

Market Cap

6.8B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$270.70

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WULF
BIO
Founded
1952
1952
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.2B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
WULF
BIO
Price
$13.86
$270.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$17.96
$358.50
AVG Volume (30 Days)
30.6M
291.7K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$168,455,000.00
N/A
Revenue This Year
$139.73
$2.51
Revenue Next Year
$178.09
$3.17
P/E Ratio
N/A
$9.72
Revenue Growth
20.28
N/A
52 Week Low
$2.06
$211.43
52 Week High
$18.51
$343.12

Technical Indicators

Market Signals
Indicator
WULF
BIO
Relative Strength Index (RSI) 42.63 39.31
Support Level $11.30 $266.71
Resistance Level $16.76 $290.01
Average True Range (ATR) 1.34 7.90
MACD -0.31 1.40
Stochastic Oscillator 2.00 47.08

Price Performance

Historical Comparison
WULF
BIO

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: